Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway

Dysregulation of the mevalonate pathway promotes transformation

James W. Clendening, Aleks Pandyra, Paul C. Boutros et al. · Proceedings of the National Academy of Sciences · 2010 · 411 citations · Full text

Medicine, Biochemistry, Oncology +13

Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.

Alain Thibault, Dvorit Samid, A Tompkins et al. · PubMed · 1996 · 361 citations

Medicine, Oncology, Pharmacology +10

Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial

Satoshi Kawata, Edna N. Yamasaki, T. Nagase et al. · British Journal of Cancer · 2001 · 355 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Cancer risk among statin users: A population‐based cohort study

Søren Friis, Aslak Harbo Poulsen, Søren Paaske Johnsen et al. · International Journal of Cancer · 2004 · 275 citations · Full text

Medicine, Oncology, Pharmacology +12

RhoA/ROCK signaling is essential for multiple aspects of VEGF‐mediated angiogenesis

Brad A. Bryan, Emily A. Dennstedt, Dianne Mitchell et al. · The FASEB Journal · 2010 · 263 citations

Life Sciences, Developmental Biology, Cell Signaling +15